Literature DB >> 1774224

Mutational analysis of leucine 47 in human epidermal growth factor.

R K Matsunami1, M L Yette, A Stevens, S K Niyogi.   

Abstract

Seven site-specific mutants (including changes to other hydrophobic, charged, and heterocyclic amino acids) of leucine 47 of human epidermal growth factor (EGF) were generated by protein engineering and characterized for their activity in three assays: radioreceptor competition binding in membrane fractions, the stimulation of the EGF receptor's tyrosine kinase activity, and the stimulation of thymidine uptake in tissue culture cells. K1/2 (concentration required for half maximum response) values for each of the mutants are reported in the three assays. The results show that the native leucine residue is quite important for EGF activity. Substitutions are tolerated to different degrees, depending upon hydrophobicity and size of the side chain. Substitution with ionic residues led to the most drastic reduction in activity. One-dimensional nuclear magnetic resonance spectroscopy, at physiological pH, of several of the mutants did not detect any major structural perturbations which would account for the loss of activity. The results suggest that the side chain of leucine 47, because of its charge neutrality, size, and hydrophobicity, is highly important, although not absolutely essential for the interaction of EGF with its receptor. A striking finding was the lower (compared with wild type) Vmax values of the mutants in the tyrosine kinase reaction, but these low Vmax mutants, in cell culture experiments, were able to stimulate at high concentrations a growth response equivalent to wild type EGF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1774224     DOI: 10.1002/jcb.240460307

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  5 in total

1.  Structural and functional aspects of the multiplicity of Neu differentiation factors.

Authors:  D Wen; S V Suggs; D Karunagaran; N Liu; R L Cupples; Y Luo; A M Janssen; N Ben-Baruch; D B Trollinger; V L Jacobsen
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

2.  A simple luciferase assay for signal transduction activity detection of epidermal growth factor displayed on phage.

Authors:  C Souriau; P Fort; P Roux; O Hartley; M P Lefranc; M Weill
Journal:  Nucleic Acids Res       Date:  1997-04-15       Impact factor: 16.971

3.  Potency and stability of C terminal truncated human epidermal growth factor.

Authors:  D P Calnan; A Fagbemi; J Berlanga-Acosta; T Marchbank; T Sizer; K Lakhoo; A D Edwards; R J Playford
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

4.  Development of an epidermal growth factor derivative with EGFR blocking activity.

Authors:  Clara Panosa; Francesc Tebar; Montserrat Ferrer-Batallé; Humphrey Fonge; Masaharu Seno; Raymond M Reilly; Anna Massaguer; Rafael De Llorens
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

Review 5.  Neuraminidase-1: a novel therapeutic target in multistage tumorigenesis.

Authors:  Fiona Haxho; Ronald J Neufeld; Myron R Szewczuk
Journal:  Oncotarget       Date:  2016-06-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.